Neurodevelopmental Disorder Therapy

Patent No. EP3407880 (titled "Neurodevelopmental Disorder Therapy") was filed by Anavex Life Sciences on Jan 24, 2017. The application was issued on Aug 17, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANDOZMay 17, 2023TER MEER STEINMEISTER & PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3407880

ANAVEX LIFE SCIENCES
Application Number
EP17703579A
Filing Date
Jan 24, 2017
Status
Opposition Rejected
Sep 6, 2024
Publication Date
Aug 17, 2022